Stocktoria
Hongchang International Co., Ltd HCIL
OTC · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1999-11-05
Hongchang International Co., Ltd (HCIL) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the grey zone. It does not currently pay a dividend.
2/9
Piotroski F — financial health
2.23
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Price from month-end closes (Yahoo) — for reference, not real-time.
Market cap$62M
Revenue trend · last 8y · down
How it ranks in Manufacturing · percentile among 1906 companies
Piotroski Fstronger than 12%
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.025 |
| Retained earnings / assets | -0.022 |
| EBIT / assets | -0.007 |
| Equity / liabilities | 2.076 |
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| HCIL | Hongchang International Co., Ltd | 2/9 | 2.23 | — | — |
| NRXS | Neuraxis, INC | 3/9 | — | — | — |
| GTHP | GUIDED THERAPEUTICS INC | 3/9 | — | — | — |
| ITOC | iTonic Holdings Ltd | 1/9 | 5.57 | — | — |
| POSC | POSITRON CORP | 2/9 | — | — | — |
| NXL | Nexalin Technology, Inc. | 4/9 | — | — | — |
| ENDV | ENDONOVO THERAPEUTICS, INC. | 3/9 | — | — | — |
FAQ
Is HCIL financially healthy?
Hongchang International Co., Ltd's Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does HCIL pay a dividend?
No, Hongchang International Co., Ltd does not currently pay a dividend.
Source: SEC EDGAR filings · CIK 0001086303 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.